PRFZ - ETF AI Analysis

Top Page

Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ)

Rating:65Neutral

Price Target:―

PRFZ, the Invesco FTSE RAFI US 1500 Small-Mid ETF, has a solid overall rating supported by strong performers like ATI, TTMI, and Primoris Services, which show robust financial results, positive earnings calls, and generally favorable technical trends. These strengths are partly offset by weaker holdings such as Opendoor Technologies and Roivant Sciences, where ongoing losses and profitability challenges weigh on the fund. The main risk factor is exposure to several companies with valuation and profitability concerns, which could add volatility even as many core holdings show healthy growth momentum.

Positive Factors

Broad Sector Diversification

The fund spreads its investments across many sectors, which helps reduce the impact if any one industry struggles.

Strong Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Multiple Strong Top Holdings

Several of the largest positions, such as Hecla Mining, TTM Technologies, and Primoris Services, have delivered strong year-to-date gains that support the fund’s overall results.

Negative Factors

Higher-Than-Index-Like Fees

The expense ratio is higher than many low-cost index ETFs, which slightly reduces the net return investors keep over time.

Single-Country Concentration

Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.

Some Lagging Top Holdings

At least one notable holding, such as Ionis Pharmaceuticals, has shown weak year-to-date performance, which can drag on the fund’s returns if the weakness continues.

PRFZ vs. SPDR S&P 500 ETF (SPY)

AUM2.67B

RegionNorth America

Expense Ratio0.34%

Beta1.03

IssuerInvesco

Inception DateSep 20, 2006

Dividend Yield0.77%

Asset ClassEquity

Index TrackedFTSE RAFI US 1500 Small-Mid Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume170,646

30 Day Avg. Volume101,740

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

59.12

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1407

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

PRFZ Summary

PRFZ is the Invesco FTSE RAFI US 1500 Small-Mid ETF, which tracks the FTSE RAFI US 1500 Small-Mid Index. It invests in a wide mix of smaller and mid-sized U.S. companies across many sectors, including health care, technology, and industrials. Some of its better-known holdings include Opendoor Technologies and Hecla Mining Company. Investors might consider PRFZ if they want long-term growth and diversification beyond the big, well-known large-cap stocks. However, because it focuses on smaller companies, its price can be more volatile and can go up and down more sharply than the overall market.

How much will it cost me?The expense ratio for the Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ) is 0.34%, which means you’ll pay $3.40 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed strategy based on fundamental factors rather than passive market-cap weighting.

What would affect this ETF?The PRFZ ETF, which focuses on small to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and healthcare, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which can disproportionately impact smaller companies and cyclical sectors like consumer discretionary and industrials. Regulatory changes or shifts in market sentiment could also affect the performance of its top holdings and sector exposure.

PRFZ Top 10 Holdings

PRFZ’s story is all about U.S. small and mid-caps, with a noticeable tilt toward health care, tech, and industrial names. Recent strength from Hecla Mining, TTM Technologies, ATI, and Primoris Services has given the fund a solid lift, as these cyclical and tech-oriented players have been rising on better earnings and momentum. Health care is more of a mixed bag: GRAIL and Roivant are climbing, but Ionis looks choppy, and Opendoor in real estate is still losing steam. Overall, performance is being driven by a broad cast rather than one dominant star.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
OPEN	Opendoor Technologies	0.65%	$18.12M	$4.65B	260.58%	53 Neutral
ROIV	Roivant Sciences	0.54%	$14.99M	$17.96B	156.44%	58 Neutral
IONS	Ionis Pharmaceuticals	0.54%	$14.88M	$14.01B	169.34%	61 Neutral
HL	Hecla Mining Company	0.54%	$14.86M	$15.26B	288.01%	74 Outperform
AEIS	Advanced Energy	0.46%	$12.77M	$10.31B	147.42%	67 Neutral
ATI	ATI	0.45%	$12.58M	$18.15B	114.62%	78 Outperform
GRAL	GRAIL Inc	0.43%	$11.99M	$3.90B	199.88%	70 Outperform
PRIM	Primoris Services	0.43%	$11.99M	$8.67B	103.92%	75 Outperform
TTMI	TTM Technologies	0.42%	$11.71M	$10.19B	284.24%	77 Outperform
AUB	Atlantic Union Bankshares	0.39%	$10.71M	$5.95B	9.18%	79 Outperform

PRFZ Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

47.46

Positive

100DMA

46.28

Positive

200DMA

43.62

Positive

Market Momentum

MACD

0.27

Positive

RSI

58.94

Neutral

STOCH

63.22

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRFZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.55, equal to the 50-day MA of 47.46, and equal to the 200-day MA of 43.62, indicating a bullish trend. The MACD of 0.27 indicates Positive momentum. The RSI at 58.94 is Neutral, neither overbought nor oversold. The STOCH value of 63.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PRFZ.

PRFZ Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
PRFZ	―	―	$2.67B	0.34%	―
JMEE	―	―	$2.36B	0.24%	―
FSMD	―	―	$2.11B	0.15%	―
CGMM	―	―	$1.51B	0.51%	―
TMSL	―	―	$1.44B	0.55%	―
USVM	―	―	$1.40B	0.29%	―

Performance Comparison

PRFZ

Invesco FTSE RAFI US 1500 Small-Mid ETF

49.09

6.53

15.34%

JMEE

JPMorgan Market Expansion Enhanced Equity ETF

―

FSMD

Fidelity Small-Mid Multifactor ETF

―

CGMM

Capital Group U.S. Small and Mid Cap ETF

―

TMSL

T. Rowe Price Small-Mid Cap ETF

―

USVM

VictoryShares USAA MSCI USA Small Cap Value Momentum ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents